Protalix and Chiesi gain positive opinion for pegunigalsidase alfa
The therapy becomes the first pegylated enzyme for the treatment of adult patients with Fabry disease
Read More
Tag: protalix
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
